At Uniquity Bio, we’re dedicated to fulfilling the promise of scientific advances that have the potential to deliver clinical innovation across a broad array of immune-mediated diseases. Our mission is inspired by our tireless commitment to putting patients first, and guided by our vast expertise in immunology and inflammation across the drug development cycle.

​

Uniquity Bio is a clinical-stage drug development company that is dedicated to bringing new patient value to the treatment of immune-mediated diseases. We’re poised to fill the unmet needs of patients across a wide range of diseases, harnessing a foundation of scientific rigor and a proven track record in R&D execution – from early development through commercialization.